Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-25T17:27:07.070Z Has data issue: false hasContentIssue false
  • English
  • Français

Obsessive-Compulsive Disorder: Boundary Issues

Published online by Cambridge University Press:  07 November 2014

Naomi A. Fineberg ,
Sanjaya Saxena ,
Joseph Zohar  and
Kevin J. Craig
Get access Rights & Permissions [Opens in a new window]

Abstract

The boundaries between obsessive-compulsive disorder (OCD) and other neuropsychiatric disorders remain unresolved and may well differ from one disorder to another. Endophenotypes are heritable, quantitative traits hypothesized to more closely represent genetic risk for complex polygenic mental disorders than overt symptoms and behaviors. They may have a role in identifying how closely these disorders are associated with another and with other mental disorders with which they share major comorbidity. This review maps the nosological relationships of OCD to other neuropsychiatric disorders, using OCD as the prototype disorder and endophenotype markers, such as cognitive, imaging, and molecular data as well as results from demographic, comorbidity, family, and treatment studies. Despite high comorbidity rates, emerging evidence suggests substantial endophenotypic differences between OCD and anxiety disorders, depression, schizophrenia, and addictions, though comparative data is lacking and the picture is far from clear. On the other hand, strong relationships between OCD, Tourette syndrome, body dysmorphic disorder, hypochondriasis, grooming disorders, obsessive-compulsive personality disorder, and pediatric autoimmune neuropsychiatric disorders associated with streptococcus are likely. Studies designed to delineate the cause, consequences, and common factors are a challenging but essential goal for future research in this area.

Type
Review Articles
Information
CNS Spectrums , Volume 12 , Issue 5 , May 2007 , pp. 359 - 375
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association; 2000.Google Scholar
2.Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005;29:399–419.CrossRefGoogle ScholarPubMed
3.Insel, TR, Mueller, EA, Alterman, I, Linnoila, M, Murphy, DL. Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry. 1985;20:1174–1188.CrossRefGoogle ScholarPubMed
4.Denys, D, van der Wee, N, Janssen, J, De Geus, F, Westenberg, HG. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry. 2004;55:1041–1045.CrossRefGoogle ScholarPubMed
5.Denys, D, Van Nieuwerburgh, F, Deforce, D, Westenberg, H. Association between the dopamine D(2) receptor Taql A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol. 2006;16:446–450.CrossRefGoogle Scholar
6.Pooley, EC, Fineberg, NA, Harrison, PJ. The met 158 allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Biol Psychiatry. In press.Google Scholar
7.Hollander, E, Wong, CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995;56(suppl 4):3–6.Google ScholarPubMed
8.Marks, I. Fears, Phobias and Rituals: Panic, Anxiety, and Their Disorders. New York, NY: Oxford University Press; 1987.Google Scholar
9.Pigott, TA, L'Heureux, F, Dubbert, B, Bernstein, S, Murphy, DL. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry. 1994;55(suppl):15–27.Google ScholarPubMed
10.Rasmussen, SA, Eisen, JL. Epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1990;51(suppl):10–13.Google ScholarPubMed
11.Shapiro, AK, Shapiro, E. Evaluation of the reported association of obsessive-compulsive symptoms or disorder with Tourette's disorder. Compr Psychiatry. 1992;33:152–165.CrossRefGoogle ScholarPubMed
12.Gottesman, II, Gould, TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–645.CrossRefGoogle ScholarPubMed
13.Hollander, E, Kim, S, Khanna, S, Pallanti, S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr. 2007;12(2 suppl 3):5–13.CrossRefGoogle Scholar
14.Hwang, MY, Morgan, JE, Losconzcy, MF. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci. 2000;12:91–94.CrossRefGoogle ScholarPubMed
15.Wittchen, HU, Jacobi, F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–376.CrossRefGoogle ScholarPubMed
16.Lochner, C, Hemmings, SM, Kinnear, CJ, et al.Gender in obsessive-compulsive disorder: clinical and genetic findings. Eur Neuropsychopharmacol. 2004;14:105–113.CrossRefGoogle ScholarPubMed
17.Hollander, E, Greenwald, S, Neville, D, Johnson, J, Hornig, CD, Weissman, MM. Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample. Depress Anxiety. 1996;4:111–119.3.0.CO;2-J>CrossRefGoogle Scholar
18.Richter, MA, Summerfeldt, LJ, Antony, MM, Swinson, RP. Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and other anxiety disorders. Depress Anxiety. 2003;18:118–127.CrossRefGoogle ScholarPubMed
19.Nestadt, G, Samuels, J, Riddle, MA, et al.The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med. 2001;31:481–487.CrossRefGoogle ScholarPubMed
20.Carter, AS, Pollock, RA, Suvak, MK, Pauls, DL. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder. Depress Anxiety. 2004;20:165–174.CrossRefGoogle Scholar
21.Fyer, AJ, Lipsitz, JD, Mannuzza, S, Aronowitz, B, Chapman, TF. A direct interview family study of obsessive-compulsive disorder. I. Psychol Med. 2005;35:1611–1621.CrossRefGoogle ScholarPubMed
22.Saxena, S. Neuroimaging and the pathophysiology of obsessive-compulsive disorder. In: Fu, CH, Senior, C, Russell, TA, Weinberger, D, Murray, R, eds. Neuroimaging in Psychiatry. London, UK: Martin Dunitz; 2003:191–224.CrossRefGoogle Scholar
23.Breiter, HC, Rauch, SL, Kwong, KK, et al.Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:595–606.CrossRefGoogle ScholarPubMed
24.Cottraux, J, Gerard, D, Cinotti, L, et al.A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res. 1996:60:101–112.CrossRefGoogle ScholarPubMed
25.McGuire, PK, Bench, CJ, Frith, CD, Marks, IM, Frackowiak, RS, Dolan, RJ. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry. 1994;164:459–468.CrossRefGoogle ScholarPubMed
26.Rauch, SL, Jenike, MA, Alpert, NM, et al.Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 1994;51:62–70.CrossRefGoogle ScholarPubMed
27.Alexander, GE, DeLong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Review Neurosci. 1986;9:357–381.CrossRefGoogle ScholarPubMed
28.Kent, JM, Rauch, SL. Neurocircuitry of anxiety disorders. Curr Psychiatry Rep. 2003;5:266–273.CrossRefGoogle ScholarPubMed
29.Schneider, F, Weiss, U, Kessler, C, et al.Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry. 1999;45:863–871.CrossRefGoogle ScholarPubMed
30.Stein, MB, Goldin, PR, Sareen, J, Zorrilla, LT, Brown, GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry. 2002;59:1027–1034.CrossRefGoogle ScholarPubMed
31.Tillfors, M, Furmark, T, Marteinsdottir, I, Fredrikson, M. Cerebral blood flow during anticipation of public speaking in social phobia: a PET study. Biol Psychiatry. 2002;52:1113–1119.CrossRefGoogle ScholarPubMed
32.Mataix-Cols, D, van den Heuvel, OA. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatr Clin North Am. 2006;29:391–410.CrossRefGoogle ScholarPubMed
33.Lucey, JV, Costa, DC, Adshead, G, et al.Brain blood flow in anxiety disorders: OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET). Br J Psychiatry. 1997;171:346–350.CrossRefGoogle ScholarPubMed
34.Airaksinen, E, Larsson, M, Forsell, Y. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res. 2005;39:207–214.CrossRefGoogle ScholarPubMed
35.Boldrini, M, Del Pace, L, Placidi, GP, et al.Selective cognitive deficits in obsessive-compulsive disorder compared to panic disorder with agoraphobia. Acta Psychiatr Scand. 2005;111:150–158.CrossRefGoogle ScholarPubMed
36.Clayton, IC, Richards, JC, Edwards, CJ. Selective attention in obsessive-compulsive disorder. J Abnorm Psychol. 1999;108:71–75.CrossRefGoogle ScholarPubMed
37.Purcell, R, Maruff, P, Kyrios, M, Pantelis, C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry. 1998;55:415–423.CrossRefGoogle ScholarPubMed
38.Cohen, Y, Lachenmeyer, JR, Springer, C. Anxiety and selective attention in obsessive-compulsive disorder. Behav Res Ther. 2003;41:1311–1323.CrossRefGoogle ScholarPubMed
39.Fineberg, NA, Gale, TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005;8:107–129.CrossRefGoogle ScholarPubMed
40.Crockett, BA, Churchill, E, Davidson, JR. A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry. 2004;16:127–132.CrossRefGoogle ScholarPubMed
41.Grady, TA, Pigott, TA, L'Heureux, F, Hill, JL, Bernstein, SE, Murphy, DL. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. Am J Psychiatry. 1993;150:819–821.Google ScholarPubMed
42.McDougle, CJ, Goodman, WK, Leckman, JF, et al.Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1993;150:647–649.Google ScholarPubMed
43.Rasmussen, SA, Goodman, WK, Woods, SW, Heninger, GR, Charney, DS. Effects of yohimbine in obsessive compulsive disorder. Psychopharmacology (Berl). 1987;93:308–313.CrossRefGoogle ScholarPubMed
44.Griez, E, de Loof, C, Pols, H, Zandbergen, J, Lousberg, H. Specific sensitivity of patients with panic attacks to carbon dioxide inhalation. Psychiatry Res. 1990;31:193–199.CrossRefGoogle ScholarPubMed
45.de Leeuw, AS, Den Boer, JA, Slaap, BR, Westenberg, HG. Pentagastrin has panic-inducing properties in obsessive compulsive disorder. Psychopharmacology (Berl). 1996;126:339–344.CrossRefGoogle ScholarPubMed
46.Bartz, JA, Hollander, E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:338–352.CrossRefGoogle ScholarPubMed
47.Fineberg, NA, Fourie, H, Gale, TM, Sivakumaran, T. Comorbid depression in obsessive compulsive disorder (OCD): symptomatic differences to major depressive disorder. J Affect Disord. 2005;87:327–330.CrossRefGoogle ScholarPubMed
48.Ravizza, L, G, Maina G, Bogetto, FEpisodic and chronic obsessive-compulsive disorder. Depress Anxiety. 1997;6:154–158.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
49.Perugi, G, Toni, C, Frare, F, Travierso, MC, Hantouche, E, Akiskal, HS. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry. 2002;63:1129–1134.CrossRefGoogle ScholarPubMed
50.Hoehn-Saric, R, Ninan, P, Black, DW, et al.Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry. 2000;57:76–82.CrossRefGoogle ScholarPubMed
51.Montgomery, SA, Kasper, S, Stein, DJ, Bang Hedegaard, K, Lemming, OM. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2001;16:75–86.CrossRefGoogle ScholarPubMed
52.Tollefson, GD, Rampey, AH Jr, Potvin, JH, et al.A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:559–567.CrossRefGoogle ScholarPubMed
53.Wheadon, DE, Bushnell, W, Steiner, M. A fixed dose comparison of 20, 40 or 60mg paroxetine to placebo in the treatment of obsessive compulsive disorde. Poster presented at: annual meeting of the American College of Neuropsychopharmacology. December 1993. Honalulu, HI.Google Scholar
54.Argyropoulos, SV, Hood, SD, Adrover, M, et al.Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry. 2004;56:503–509.CrossRefGoogle ScholarPubMed
55.Barr, LC, Goodman, WK, McDougle, CJ, et al.Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry. 1994;51:309–317.CrossRefGoogle ScholarPubMed
56.Vielhaber, K, Riemann, D, Feige, B, Kuelz, A, Kirschbaum, C, Voderholzer, U. Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations. Pharmacopsychiatry. 2005;38:87–94.CrossRefGoogle ScholarPubMed
57.Chamberlain, SR, Fineberg, NA, Menzies, LA, et al.Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164:335–338.CrossRefGoogle ScholarPubMed
58.Bearden, CE, Hoffman, KM, Cannon, TDThe neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord. 2001;3:106–150.CrossRefGoogle ScholarPubMed
59.Veiel, HO. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol. 1997;19:587–603.CrossRefGoogle ScholarPubMed
60.Clark, L, Iversen, SD, Goodwin, GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry. 2002;180:313–319.CrossRefGoogle ScholarPubMed
61.Clark, L, Sarna, A, Goodwin, GM. Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression. Am J Psychiatry. 2005;162:1980–1982.CrossRefGoogle Scholar
62.Chamberlain, SR, Fineberg, NA, Blackwell, AD, Robbins, TW, Sahakian, BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotil-lomania. Am J Psychiatry. 2006;163:1282–1284.CrossRefGoogle Scholar
63.Berrios, GE. Obsessive compulsive disorders. In: Berrios, GE, Porter, R, eds. A History of Clinical Psychiatry: The Origin and History of Psychiatric Disorders. London, UK: Athlone Press; 1995;573–598.Google Scholar
64.Luchins, DJ, Goldman, MB, Lieb, M, Hanrahan, P. Repetitive behaviors in chronically institutionalized schizophrenic patients. Schizophr Res. 1992;8:119–123.CrossRefGoogle ScholarPubMed
65.Tracy, JI, de Leon, J, Qureshi, G, McCann, EM, McGrory, A, Josiassen, RC. Repetitive behaviors in schizophrenia: a single disturbance or discrete symptoms? Schizophr Res. 1996;20:221–229.CrossRefGoogle ScholarPubMed
66.Abbruzzese, M, Ferri, S, Scarone, S. The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia. 199;35:907–912.CrossRefGoogle Scholar
67.Cavallaro, R, Cavedini, P, Mistretta, P, et al.Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry. 2003;54:437–443.CrossRefGoogle ScholarPubMed
68.Goldstein, JM, Goodman, JM, Seidman, LJ, et al.Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry. 1999;56:537–547.CrossRefGoogle ScholarPubMed
69.Meador-Woodruff, JH, Haroutunian, V, Powchik, P, Davidson, M, Davis, KL, Watson, SJ. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry. 1997;54:1089–1095.CrossRefGoogle ScholarPubMed
70.Silbersweig, DA, Stern, E, Frith, C, et al.A functional neuroanatomy of hallucinations in schizophrenia. Nature. 1995;378:176–179.CrossRefGoogle ScholarPubMed
71.Saxena, S, Rauch, SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563–586.CrossRefGoogle ScholarPubMed
72.Lysaker, PH, Bryson, GJ, Marks, KA, Greig, TC, Bell, MD. Association of obsessions and compulsions in schizophrenia with neurocognition and negative symptoms. J Neuropsychiatry Clin Neurosci. 2002;14:449–453.CrossRefGoogle ScholarPubMed
73.Lysaker, PH, Marks, KA, Picone, JB, Rollins, AL, Fastenau, PS, Bond, GR. Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis. 2000;188:78–83.CrossRefGoogle ScholarPubMed
74.Whitney, KA, Fastenau, PS, Evans, JD, Lysaker, PH. Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms. Schizophr Res. 2004;69:75–83.CrossRefGoogle ScholarPubMed
75.Irle, E, Exner, C, Thielen, K, Weniger, G, Ruther, E. Obsessive-compulsive disorder and ventromedial frontal lesions: clinical and neuropsychological findings. Am J Psychiatry. 1998;155:255–263.CrossRefGoogle ScholarPubMed
76.Karayiorgou, M, Altemus, M, Galke, BL, et al.Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A. 1997;94:4572–4575.CrossRefGoogle ScholarPubMed
77.Lochner, C, Kinnear, CJ, Hemmings, SM, et al.Hoarding in obsessive-compulsive disorder: clinical and genetic correlates. J Clin Psychiatry. 2005;66:1155–1160.CrossRefGoogle ScholarPubMed
78.Zubieta, JKHeitzeg, MM, Smith, YR, et al.COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240–1243.CrossRefGoogle ScholarPubMed
79.Stein, DJ, Newman, TK, Savitz, J, Ramesar, R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr. 2006;11:745–748.CrossRefGoogle ScholarPubMed
80.Fineberg, NA, Gale, TM, Sivakumaran, T. A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol. 2006;20:97–103.CrossRefGoogle ScholarPubMed
81.Everitt, BJ, Robbins, TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8:1481–1489.CrossRefGoogle ScholarPubMed
82.Hesse, SU, Muller, U, Lincke, T, et al.Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res. 2005;140:63–72.CrossRefGoogle ScholarPubMed
83.Volkow, ND, Chang, L, Wang, GJ, et al.Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry. 2001;158:383–389.CrossRefGoogle ScholarPubMed
84.Volkow, ND, Fowler, JS, Wang, GJ, et al.Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14:169–177.CrossRefGoogle ScholarPubMed
85.Volkow, ND, Fowler, JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10:318–325.CrossRefGoogle ScholarPubMed
86.van der Wee, NJ, Stevens, H, Hardeman, JA, et al.Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [1231]{beta}-CIT SPECT. Am J Psychiatry. 2004;161:2201–2206.CrossRefGoogle ScholarPubMed
87.Berman, I, Merson, A, Viegner, B, Losonczy, MF, Pappas, D, Green, Al. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998;186:150–156.CrossRefGoogle ScholarPubMed
88.Borkowska, A, Pilaczynska, E, Rybakowski, JK. The frontal lobe neuropsychological tests in patients with schizophrenia and/or obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 2003;15:359–362.CrossRefGoogle ScholarPubMed
89.Ongur, D, Goff, DC. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res. 2005;75:349–362.CrossRefGoogle ScholarPubMed
90.Hermesh, H, Weizman, A, Gur, S, et al.Alternation learning in OCD/schizophrenia patients. Eur Neuropsychopharmacol. 2003;13:87–91.CrossRefGoogle ScholarPubMed
91. Baxter LR, Jr, Phelps, ME, Mazziotta, JC, Guze, BH, Schwartz, JM, Selin, CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44:211–218.Google Scholar
92.Volkow, ND, Fowler, JS, Wang, GJ, Swanson, JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004;9:557–569.CrossRefGoogle ScholarPubMed
93.Wilson, JM, Kalasinsky, KS, Levey, Al, et al.Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med. 1996;2:699–703.CrossRefGoogle ScholarPubMed
94.Nestler, EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001;2:119–128.CrossRefGoogle ScholarPubMed
95.Fillmore, MT, Rush, CR. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend. 2002;66:265–273.CrossRefGoogle ScholarPubMed
96.Moeller, FG, Dougherty, DM, Barratt, ES, et al.Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend. 2002;68:105–111.CrossRefGoogle ScholarPubMed
97.Grant, JE, Brewer, JA, Potenza, MN. The neurobiology of substance and behavioral addictions. CNS Spectr. 2006;11:924–930.CrossRefGoogle ScholarPubMed
98.Potenza, MN, Leung, HC, Blumberg, HP, et al.An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry. 2003;160:1990–1994.CrossRefGoogle ScholarPubMed
99.Siever, LJ, Buchsbaum, MS, New, AS, et al.d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 1999;20:413–423.CrossRefGoogle ScholarPubMed
100.Dodd, ML, Klos, KJ, Bower, JH, Geda, YE, Josephs, KA, Ahlskog, JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol. 2005;62:1377–1381.CrossRefGoogle ScholarPubMed
101. Di Ciano, P, Underwood, RJ, Hagan, JJ, Everitt, BJ. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology. 2003;28:329–338.CrossRefGoogle ScholarPubMed
102.du Toit, PL, van Kradenburg, J, Niehaus, D, Stein, DJ. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry. 2001;42:291–300.CrossRefGoogle ScholarPubMed
103.Gunstad, J, Phillips, KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44:270–276.CrossRefGoogle ScholarPubMed
104.Chamberlain, SR, Menzies, L, Sahakian, BJ, Fineberg, NA. Lifting the veil on trichotillomania. Am J Psychiatry. 2007;164:568–574.CrossRefGoogle ScholarPubMed
105.Bienvenu, OJ, Samuels, JF, Riddle, MA, et al.The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48:287–293.CrossRefGoogle ScholarPubMed
106.Grados, MA, Riddle, MA, Samuels, JF, et al.The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol Psychiatry. 2001;50:559–565.CrossRefGoogle ScholarPubMed
107.Fontenelle, LF, Telles, LL, Nazar, BP, et al.A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil. Int J Psychiatry Med. 2006;36:243–259.CrossRefGoogle ScholarPubMed
108.Phillips, KA, Pinto, A, Menard, W, Eisen, JL, Mancebo, M, Rasmussen, SA. Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders. Depress Anxiety. 2006 Oct 13; [Epub ahead of print].Google Scholar
109.Heimann, SW. SSRI for body dysmorphic disorder. J Am Acad Child Adolesc Psychiatry. 1997;36:868.CrossRefGoogle ScholarPubMed
110.Perkins, RJ. SSRI antidepressants are effective for treating delusional hypochondriasis. Med J Aust. 1999;170:140–141.CrossRefGoogle ScholarPubMed
111.Barsky, AJ, Ahern, DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004;291:464–470.CrossRefGoogle ScholarPubMed
112.Castle, DJ, Rossell, S, Kyrios, M. Body dysmorphic disorder. Psychiatr Clin North Am. 2006;29:521–538.CrossRefGoogle ScholarPubMed
113.Ninan, PT, Rothbaum, BO, Marsteller, FA, Knight, BT, Eccard, MB. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry. 2000;61:47–50.CrossRefGoogle ScholarPubMed
114.Rapp, JT, Miltenberger, RG, Long, ES, Elliott, AJ, Lumley, VA. Simplified habit reversal treatment for chronic hair pulling in three adolescents: a clinical replication with direct observation. J Appl Behav Anal. 1998;31:299–302.CrossRefGoogle ScholarPubMed
115.Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. Strategy implementation in obsessive-compulsive disorder and trichotillomania. Psychol Med. 2006;36:91–97.CrossRefGoogle ScholarPubMed
116.O'Sullivan, RL, Rauch, SL, Breiter, HC, et al.Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry. 1997;42:39–45.CrossRefGoogle ScholarPubMed
117.Keuthen, NJ, Makris, N, Schlerf, JE, et al.Evidence for reduced cerebellar volumes in trichotillomania. Biol Psychiatry. 2007;61:374–381.CrossRefGoogle ScholarPubMed
118.Swedo, SE, Rapoport, JL, Leonard, HL, Schapiro, MB, Rapoport, SI, Grady, CL. Regional cerebral glucose metabolism of women with trichotillomania. Arch Gen Psychiatry. 1991;48:828–833.CrossRefGoogle ScholarPubMed
119.Rauch, SL, Shin, LM, Dougherty, DD, Alpert, NM, Fischman, AJ, Jenike, MA. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology. 2002;27:782–791.CrossRefGoogle ScholarPubMed
120.van den Heuvel, OA, Veltman, DJ, Groenewegen, HJ, et al.Disorder-specific neuro-anatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry. 2005;62:922–933.CrossRefGoogle Scholar
121.Carey, P, Seedat, S, Warwick, J, van Heerden, B, Stein, DJ. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci. 2004;16:357–359.CrossRefGoogle ScholarPubMed
122.Stein, DJ. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry. 2000;47:296–304.CrossRefGoogle ScholarPubMed
123.Baer, L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry. 1994;55(suppl):18–23.Google ScholarPubMed
124.Leckman, JF, Grice, DE, Boardman, J, et al.Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154:911–917.Google ScholarPubMed
125.Mataix-Cols, D, Rauch, SL, Manzo, PA, Jenike, MA, Baer, L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409–1416.CrossRefGoogle ScholarPubMed
126.Park, S, Como, PG, Cui, L, Kurlan, R. The early course of the Tourette's syndrome clinical spectrum. Neurology. 1993;43:1712–1715.CrossRefGoogle ScholarPubMed
127.Pauls, DL, Towbin, KE, Leckman, JF, Zahner, GE, Cohen, DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986;43:1180–1182.CrossRefGoogle ScholarPubMed
128.Rosario-Campos, MC, Leckman, JF, Mercadante, MT, et al.Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158:1899–1903.CrossRefGoogle ScholarPubMed
129.Samuels, J, Bienvenu, OJ 3rd, Riddle, MA, et al.Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther. 2002;40:517–528.CrossRefGoogle ScholarPubMed
130.Leckman, JF, Zhang, H, Alsobrook, JP, Pauls, DL. Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genet. 2001;105:28–30.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
131.Pauls, DL, Leckman, JF, Towbin, KE, Zahner, GE, Cohen, DJ. A possible genetic relationship exists between Tourette's syndrome and obsessive-compulsive disorder. Psychopharmacol Bull. 1986;22:730–733.Google ScholarPubMed
132.Zhang, H, Leckman, JF, Pauls, DL, et al.Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet. 2002;70:896–904.CrossRefGoogle ScholarPubMed
133.Peterson, BS, Thomas, P, Kane, MJ, et al.Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry. 2003;60:415–424.CrossRefGoogle ScholarPubMed
134.Braun, AR, Randolph, C, Stoetter, B, et al.The functional neuroanatomy of Tourette's syndrome: an FDG-PET Study. II: relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology. 1995;13:151–168.CrossRefGoogle ScholarPubMed
135.Stern, E, Silbersweig, DA, Chee, KY, et al.A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry. 2000;57:741–748.CrossRefGoogle ScholarPubMed
136.Watkins, LH, Sahakian, BJ, Robertson, MM, et al.Executive function in Tourette's syndrome and obsessive-compulsive disorder. Psychol Med. 2005;35:571–582.CrossRefGoogle ScholarPubMed
137.Albin, RL, Koeppe, RA, Bohnen, NI, et al.Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 2003;61:310–315.CrossRefGoogle ScholarPubMed
138.Albin, RL, Mink, JW. Recent advances in Tourette syndrome research. Trends Neurosci. 2006;29:175–182.CrossRefGoogle ScholarPubMed
139.Freeman, CP, Trimble, MR, Deakin, JF, et al.Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry. 1994;55:301–305.Google ScholarPubMed
140.Gilbert, D. Treatment of children and adolescents with tics and Tourette syndrome. J Child Neurol. 2006;21:690–700.CrossRefGoogle ScholarPubMed
141.Gilbert, DL, Bansal, AS, Sethuraman, G, et al.Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord. 2004;19:416–425.CrossRefGoogle ScholarPubMed
142.Gilbert, DL, Wang, Z, Sallee, FR, et al.Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain. 2006;129:2038–2046.CrossRefGoogle ScholarPubMed
143.Goodman, WK, McDougle, CJ, Price, LH, et al.Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry. 1990;51(suppl):36–43.Google ScholarPubMed
144.George, MS, Trimble, MR, Ring, HA, Sallee, FR, Robertson, MM. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry. 1993;150:93–97.Google ScholarPubMed
145.Bejerot, S, Ekselius, L, von Knorring, L. Comorbidity between obsessive-compulsive disorder (OCD) and personality disorders. Acta Psychiatr Scand. 1998;97:398–402.CrossRefGoogle ScholarPubMed
146.Baer, L, Jenike, MA. Personality disorders in obsessive compulsive disorder. Psychiatr Clin North Am. 1992;15:803–812.CrossRefGoogle ScholarPubMed
147.Diaferia, G, Bianchi, I, Bianchi, ML, Cavedini, P, Erzegovesi, S, Bellodi, L. Relationship between obsessive-compulsive personality disorder and obsessive-compulsive disorder. Compr Psychiatry. 1997;38:38–42.CrossRefGoogle ScholarPubMed
148.Mataix-Cols, D, Baer, L, Rauch, SL, Jenike, MA. Relation of factor-analyzed symptom dimensions of obsessive-compulsive disorder to personality disorders. Acta Psychiatr Scand. 2000;102:199–202.CrossRefGoogle ScholarPubMed
149.Matsunaga, H, Kiriike, N, Matsui, T, et al.Gender differences in social and interpersonal features and personality disorders among Japanese patients with obsessive-compulsive disorder. Compr Psychiatry. 2000;41:266–272.CrossRefGoogle ScholarPubMed
150.Matsunaga, H, Kiriike, N, Miyata, A, et al.Personality disorders in patients with obsessive-compulsive disorder in Japan. Acta Psychiatr Scand. 1998;98:128–134.CrossRefGoogle ScholarPubMed
151.Mavissakalian, M, Hamann, MS, Jones, B. Correlates of DSM-III personality disorder in obsessive-compulsive disorder. Compr Psychiatry. 1990;31:481–489.CrossRefGoogle ScholarPubMed
152.Samuels, J, Nestadt, G, Bienvenu, OJ, et al.Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry. 2000;177:457–462.CrossRefGoogle ScholarPubMed
153.Norman, RM, Davies, F, Malla, AK, Cortese, L, Nicholson, IR. Relationship of obsessive-compulsive symptomatology to anxiety, depression and schizotypy in a clinical population. Br J Clin Psychol. 1996;3:553–566.CrossRefGoogle Scholar
154.Thomsen, PH, Mikkelsen, HU. Development of personality disorders in children and adolescents with obsessive-compulsive disorder. A 6- to 22-year follow-up study. Acta Psychiatr Scand. 1993;87:456–462.CrossRefGoogle ScholarPubMed
155.Kolada, JL, Bland, RC, Newman, SC. Epidemiology of psychiatric disorders in Edmonton. Obsessive-compulsive disorder. Acta Psychiatr Scand Suppl. 1994;376:24–35.CrossRefGoogle ScholarPubMed
156.Nestadt, G, Samuels, JF, Romanoski, AJ, Folstein, MF, McHugh, PR. Obsessions and compulsions in the community. Acta Psychiatr Scand. 1994;89:219–224.CrossRefGoogle ScholarPubMed
157.Black, DW, Noyes, R Jr, Pfohl, B, Goldstein, RB, Blum, N. Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives. Am J Psychiatry. 1993;150:1226–1232.Google ScholarPubMed
158.Alnaes, R, Torgersen, S. DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population. Acta Psychiatr Scand. 1988;78:348–355.CrossRefGoogle Scholar
159.Pfohl, B, Black, DW, Noyes, R, Coryell, WH, Barrash, J. Axis I and Axis II comorbidity findings: implications for validity. In: Oldham, JM, ed. Personality Disorders: New Perspectives on Diagnostic Validity. Washington, DC: American Psychiatric Press. 1990:147–161.Google Scholar
160.Stanley, MA, Turner, SM, Borden, JW. Schizotypal features in obsessive-compulsive disorder. Compr Psychiatry. 1990;31:511–518.CrossRefGoogle ScholarPubMed
161.Baer, L, Jenike, MA, Ricciardi, JN 2nd, et al.Standardized assessment of personality disorders in obsessive-compulsive disorder. Arch Gen Psychiatry. 1990;47:826–830.CrossRefGoogle ScholarPubMed
162.Joffe, RT, Swinson, RP, Regan, JJ. Personality features of obsessive-compulsive disorder. Am J Psychiatry. 1988;145:1127–1129.Google ScholarPubMed
163.Eisen, JL. Obsessive compulsive personality disorder: its treatment and relationship to OCD. Paper presented at: annual meeting of American Psychiatric Association. May 2004; New York, NY.Google Scholar
164.Dinn, WM, Harris, CL, Aycicegi, A, Greene, P, Andover, MS. Positive and negative schizotypy in a student sample: neurocognitive and clinical correlates. Schizophr Res. 2002;56:171–185.CrossRefGoogle Scholar
165.Mercadante, MT, Busatto, GF, Lombroso, PJ, et al.The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000;157:2036–2038.CrossRefGoogle ScholarPubMed
166.Slattery, MJ, Dubbert, BK, Allen, AJ, Leonard, HL, Swedo, SE, Gourley, MF. Prevalence of obsessive-compulsive disorder in patients with systemic lupus erythematosus. J Clin Psychiatry. 2004;65:301–306.CrossRefGoogle ScholarPubMed
167.Murphy, TK, Sajid, MW, Goodman, WK. Immunology of obsessive-compulsive disorder. Psychiatr Clin North Am. 2006;29:445–469.CrossRefGoogle ScholarPubMed
168.Swedo, SE, Leonard, HL, Garvey, M, et al.Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–271.CrossRefGoogle ScholarPubMed
169.Carapetis, JR, Currie, BJ. Rheumatic chorea in northern Australia: a clinical and epidemiological study. Arch Dis Child. 1999;80:353–358.CrossRefGoogle Scholar
170.Hounie, AG, Pauls, DL, do Rosario-Campos, MC, et al.Obsessive-compulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry. 2007;61:266–272.CrossRefGoogle ScholarPubMed
171.Dale, RC, Heyman, I, Giovannoni, G, Church, AW. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry. 2005;187:314–319.CrossRefGoogle ScholarPubMed
172.Arnold, PD, Richter, MA. Is obsessive-compulsive disorder an autoimmune disease? CMAJ. 2001;165:1353–1358.Google ScholarPubMed
173.Asbahr, FR, Garvey, MA, Snider, LA, Zanetta, DM, Elkis, H, Swedo, SE. Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry. 2005;57:1073–1076.CrossRefGoogle ScholarPubMed
174.Storch, EA, Murphy, TK, Geffken, GR, et al.Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006;45:1171–1178.CrossRefGoogle ScholarPubMed
175.Bejerot, S, Humble, M. Low prevalence of smoking among patients with obsessive-compulsive disorder. Compr Psychiatry. 1999;40:268–272.CrossRefGoogle ScholarPubMed
176.Szechtman, H, Sulis, W, Eilam, D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci. 1998;112:1475–1485.CrossRefGoogle ScholarPubMed
177.Steketee, G, Frost, R. Compulsive hoarding: current status of the research. Clin Psychol Rev. 2003;23:905–927.CrossRefGoogle ScholarPubMed
178.Grilo, CM, McGlashan, TH, Morey, LC, et al.Internal consistency, intercriterion overlap and diagnostic efficiency of criteria sets for DSM-IV schizotypal, borderline, avoidant and obsessive-compulsive personality disorders. Acta Psychiatr Scand. 2001;104:264–272.CrossRefGoogle ScholarPubMed